DOI: 10.1161/circ.148.suppl_1.14274 ISSN: 0009-7322

Abstract 14274: Management of Severe Asymptomatic Carotid Stenosis, Best Medical versus Stenting versus Endarterectomy, a Network Meta Analysis of Randomized Controlled Trials

Ahmed K. Awad, Mohamed T Abuelazm, Mohamed Elzeftawy, Ibrahim Gowaily, Hassen Abdalshafy, Adel Mouffokes, Shafaqat Ali, Basel Abdelazeem
  • Physiology (medical)
  • Cardiology and Cardiovascular Medicine
Show PDF Cite

Background: We conducted a network meta-analysis to investigate the efficacy and safety of best medical therapy (BMT) versus carotid artery stenting (CAS) versus carotid endarterectomy (CEA) in patients with severe asymptomatic carotid stenosis.

Methods: We systematically searched Web of Science, SCOPUS, EMBASE, PubMed, and Cochrane Central till March 1 st , 2023, to include any randomized control trial (RCT) that assesses the efficacy of BMT, CAS, or CEA in the management of severe asymptomatic carotid stenosis. A network meta-analysis was conducted using R software pooling dichotomous outcomes using risk ratio (RR) and 95% confidence interval (CI).

Results: Eight RCTs with 10,094 patients were included. Compared to BMT, both CAS and CEA showed a statistically significant higher risk of the 30 days composite (stroke, myocardial infarction (MI), and mortality) (RR: 4.37 [95% CI 2.35 - 8.11]) (RR: 4.04 [95% CI 2.08 - 7.85]), respectively; mortality (RR: 6.93 [95% CI 1.60 - 29.98]) (RR: 8.12 [95% CI 1.88 - 35.16]), respectively; MI with (RR: 16.03 [95% CI 1.96 - 26.14]) (RR: 27.51 [95% CI 1.65 - 45.46]), respectively; and stroke (RR: 3.42 [95% CI 1.70 - 6.88]) (RR: 2.48 [95% CI 1.23 - 4.99]), respectively. However, both CAS and CEA did not show statistically significant differences between BMT five-year mortality and MI. Finally, CEA showed a statistically significant lower risk of 5-year restenosis with (RR: 0.38 [95% CI 0.12 - 0.88]) and stroke (RR: 0.27 [95% CI 0.22 - 0.98]) compared to BMT.

Conclusion: BMT for severe asymptomatic carotid stenosis holds an equal efficacy compared to CSA and CEA, yet an even lower risk regarding short-term outcomes. However, CEA shows a lower risk compared to BMT and CSA in terms of long-term (five-year) stroke and restenosis. Further research is still warranted to clarify which patients can benefit most from invasive strategies and to furtherly investigate BMT due to the currently limited evidence.

More from our Archive